Trulieve Cannabis (TCNNF) EPS (Weighted Average and Diluted) (2020 - 2025)
Trulieve Cannabis (TCNNF) has 6 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.24 in Q4 2025.
- For Q4 2025, EPS (Weighted Average and Diluted) rose 11.11% year-over-year to -$0.24; the TTM value through Dec 2025 reached -$0.58, up 26.58%, while the annual FY2025 figure was -$0.58, 26.58% up from the prior year.
- EPS (Weighted Average and Diluted) reached -$0.24 in Q4 2025 per TCNNF's latest filing, down from -$0.11 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.31 in Q2 2021 and bottomed at -$1.8 in Q2 2023.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.22, with a median of -$0.16 recorded in 2022.
- Peak YoY movement for EPS (Weighted Average and Diluted): crashed 4900.0% in 2021, then soared 97.78% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.48 in 2021, then skyrocketed by 33.33% to -$0.32 in 2022, then surged by 40.63% to -$0.19 in 2023, then crashed by 42.11% to -$0.27 in 2024, then rose by 11.11% to -$0.24 in 2025.
- Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.24 in Q4 2025, -$0.11 in Q3 2025, and -$0.07 in Q2 2025.